INDV compared with VISN: revenue, margins and what each company keeps, and the suppliers and customers both name

INDVIndivior Pharmaceuticals, Inc.

Mkt capRevenueRevenue

VISNVistance Networks, Inc.

Mkt capRevenueRevenue

Compare

INDVIndivior Pharmaceuticals, Inc.

VISNVistance Networks, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

INDV

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±12.3%▲+1.38%×0.11

Q2 FY26—▼−6.60%—

Q1 FY26±12.8%▲+7.70%×0.60

Feb 26 '26±13.8%▲+0.24%×0.01

VISN

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.6%▼−18.22%×1.90

Apr 30 '26±4.9%▲+22.21%×4.53

= impliedINDV realized, solidVISN realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedspan: INDV 245d · VISN 161dSource: market data

Q1 FY26

±5.8%

▲+0.16%

×0.03

Feb 26 '26±6.3%▲+0.11%×0.02

INDVIndivior Pharmaceuticals, Inc.

36.27· pre 36.50· delayed

Mkt cap$4.2BRevenue$356MQ3 FY26Revenue$1.2BFY25

VISNVistance Networks, Inc.

6.49· pre 6.49· delayed

Pre-marketNov 2 '26delayed

Mkt cap$1.5BRevenue$320MQ2 FY26Revenue—

Compare

Pre-marketNov 2 '26delayed

INDVIndivior Pharmaceuticals, Inc.

VISNVistance Networks, Inc.

36.27pre 36.50delayed

Price

6.49pre 6.49delayed

$4.2B

Mkt cap

$1.5B

Q3 FY26$356M

Revenue

$320MQ2 FY26

FY25$1.2B

Revenue

—

INDV36.27vsVISN6.49Pre-marketNov 2 '26delayed